XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2
Contingent Consideration - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Nov. 24, 2021
USD ($)
right
Jun. 09, 2020
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Business Acquisition [Line Items]            
Fair value of contingent consideration   $ 230,000        
Payment of contingent consideration         $ 22,900 $ 0
Fair value of excess of the acquisition         2,100  
Change in fair value of contingent consideration     $ 743 $ (8,750) 1,408 (7,730)
USWM Enterprises            
Business Acquisition [Line Items]            
Change in fair value of contingent consideration     300 $ (8,800) 2,100 $ (7,700)
Adamas Pharmaceuticals            
Business Acquisition [Line Items]            
Fair value of contingent consideration $ 10,307          
Change in fair value of contingent consideration     $ 400   (700)  
Contingents vale rights | right 2          
SPN-830 Regulatory and Commercial Activities            
Business Acquisition [Line Items]            
Fair value of contingent consideration   130,000        
SPN-830 NDA Approval Milestone            
Business Acquisition [Line Items]            
Fair value of contingent consideration   105,000        
SPN-830 Future Sales Performance            
Business Acquisition [Line Items]            
Fair value of contingent consideration   100,000        
SPN-830 First Commercial And Sale            
Business Acquisition [Line Items]            
Fair value of contingent consideration   100,000        
APOKYN            
Business Acquisition [Line Items]            
Fair value of contingent consideration   35,000        
APOKYN and SPN-830            
Business Acquisition [Line Items]            
Fair value of contingent consideration   65,000        
SPN-830 FDA Acceptance Milestone            
Business Acquisition [Line Items]            
Fair value of contingent consideration   25,000        
SPN-830 NDA Approval Milestone, Time-Based            
Business Acquisition [Line Items]            
Fair value of contingent consideration   $ 50,000        
SPN-830 NDA Approval Milestone, Approval-Based            
Business Acquisition [Line Items]            
Fair value of contingent consideration         $ 55,000